Evidence map›Paper›PMID 38327056›Full record

ArticleBiophysical journal2024

Chemokine receptor distribution on the surface of repolarizing T cells.

Jessica K Mazalo, Szun S Tay, Daryan Kempe, Maté Biro

Abstract read
In one paragraph

Article in Biophysical journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Biophysics of immune cell signaling.Biophysical journal · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jessica K MazaloEMBL Australia, Single Molecule Science Node, School of Biomedical Sciences, University of New South Wales, Sydney, NSW, Australia.
Szun S TayEMBL Australia, Single Molecule Science Node, School of Biomedical Sciences, University of New South Wales, Sydney, NSW, Australia.
Daryan KempeEMBL Australia, Single Molecule Science Node, School of Biomedical Sciences, University of New South Wales, Sydney, NSW, Australia. Electronic address: d.kempe@unsw.edu.au.
Maté BiroEMBL Australia, Single Molecule Science Node, School of Biomedical Sciences, University of New South Wales, Sydney, NSW, Australia. Electronic address: m.biro@unsw.edu.au.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

T cells migrate constitutively with a polarized morphology, underpinned by signaling compartmentalization and discrete cytoskeletal organizations, giving rise to a dynamic and expansive leading edge, distinct from the stable and constricted uropod at the rear. In vivo, the motion and function of T cells at various stages of differentiation is highly directed by chemokine gradients. When cognate ligands bind chemokine receptors on their surface, T cells respond by reorientating their polarity axis and migrating toward the source of the chemokine signal. Despite the significance of such chemotactic repolarization to the accurate navigation and function of T cells, the precise signaling mechanisms that underlie it remain elusive. Notably, it remained unclear whether the distribution of chemokine receptors on the T cell surface is altered during repolarization. Here, we developed parallel cell-secreted and microfluidics-based chemokine gradient delivery methods and employed both fixed imaging and live lattice light-sheet microscopy to investigate the dynamics of chemokine receptor CCR5 on the surface of primary murine CD8

Indexed as

Receptors, CCR5AnimalsCD8-Positive T-LymphocytesCell MembraneCell MovementCell PolarityMiceMice, Inbred C57BLReceptors, ChemokineT-LymphocytesReceptors, CCR5Receptors, Chemokine

Identifiers

PMID38327056
PMCPMC11331047

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.